AI assistant
Sending…
Atea Pharmaceuticals, Inc. — Director's Dealing 2021
May 21, 2021
33577_dirs_2021-05-20_a45aaa94-1a02-4642-8be7-d7f9a727d36d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Atea Pharmaceuticals, Inc. (AVIR)
CIK: 0001593899
Period of Report: 2021-05-18
Reporting Person: Adams Jerome M. (Director)
More from Atea Pharmaceuticals, Inc.
Proxy Solicitation & Information Statement
2026
Apr 27
Major Shareholding Notification
2026
Feb 9
Director's Dealing
2026
Feb 3
Director's Dealing
2026
Feb 3
Director's Dealing
2026
Feb 3
Director's Dealing
2026
Feb 3
Director's Dealing
2026
Feb 3
Director's Dealing
2026
Feb 3
Regulatory Filings
2026
Jan 8
Major Shareholding Notification
2025
Dec 5